| 10x Science | US | seed | $4.8M |
| 1849 bio | US | seed | $500,000 |
| 20 Bio, Inc. | US | unknown | $3.0M |
| 3-C INSTITUTE FOR SOCIAL DEVELOPMENT INC | US | unknown | $1.9M |
| AAPlasma LLC | US | unknown | $850,000 |
| ABBRATECH INC. | US | unknown | $2.2M |
| Actithera | NO | series-a | $86.4M |
| ACURASTEM INC | US | unknown | $2.9M |
| ADAMAS NANOTECHNOLOGIES INC | US | unknown | $2.0M |
| Adcendo | DK | series-b+ | $150.0M |
| Adcytherix | FR | series-a | $145.8M |
| Adela, Inc. | US | unknown | $60.0M |
| Adjuvax LLC | US | unknown | $3.0M |
| ADVERTENT BIOTHERAPEUTICS, INC. | US | unknown | $1.3M |
| Aethl Bio, Inc. | US | seed | $2.0M |
| Affinity Biosensors | US | unknown | $2.3M |
| Agroloop | HU | series-a | $27.0M |
| AI Proteins | US | series-a | $41.5M |
| AIQ GLOBAL INC | US | unknown | $2.0M |
| Akribion Therapeutics | DE | seed | $8.6M |
| Akribion Therapeutics | DE | seed | $8.6M |
| ALARA IMAGING INC | US | unknown | $2.0M |
| Alchemab Therapeutics | GB | series-a | $116.6M |
| Alcolase | DK | seed | $1.6M |
| ALDATU BIOSCIENCES INC | US | unknown | $2.0M |
| ALIDA BIOSCIENCES INC. | US | unknown | $2.2M |
| ALLERDIA INC | US | unknown | $2.0M |
| Alleviant Medical, Inc. | US | unknown | $2.0M |
| ALLYX THERAPEUTICS INC | US | unknown | $23.0M |
| ALP Bio | CH | pre-seed | $2.1M |
| ALP Bio | CH | pre-seed | $2.1M |
| ALPENGLOW BIOSCIENCES, INC. | US | unknown | $2.0M |
| Alume Biosciences Inc | US | series-b+ | $3.1M |
| Ambrosia Biosciences | US | series-b+ | $150.0M |
| AMIDEBIO, LLC | US | unknown | $1.9M |
| Amphix Bio, Inc. | US | unknown | $10.3M |
| Amplifold | DE | seed | $5.4M |
| Amplo Biotechnology, Inc. | US | unknown | $4.0M |
| ANALYTICS HQ, LLC | US | unknown | $2.0M |
| Antares Therapeutics | US | series-a | $177.0M |
| Anthrogen | US | seed | $1.0M |
| Antler Bio | GB | seed | $9.2M |
| APMONIA THERAPEUTICS | FR | unknown | $2.6M |
| Apoha | GB | seed | $36.0M |
| APPLIED BIOPHYSICS, INC. | US | unknown | $1.8M |
| Aqemia | FR | series-a | $32.4M |
| AQUALUNG THERAPEUTICS, CORP | US | unknown | $3.0M |
| Arborea | GB | seed | $5.4M |
| ArgusEye AB | SE | unknown | $2.7M |
| ARISAN THERAPEUTICS INC | US | unknown | $2.0M |
| Arkea Bio Corp. | US | unknown | $7.0M |
| ARONORA INC | US | unknown | $2.8M |
| Arsenale BioYards | IT | seed | $10.3M |
| Arsenale BioYards | IT | seed | $9.7M |
| Artbio | US | series-b+ | $243.0M |
| ARTERY THERAPEUTICS INC | US | unknown | $2.5M |
| Artos | US | seed | $500,000 |
| ASAKE BIOTECHNOLOGY, LLC | US | unknown | $2.0M |
| Ascent Bio-Nano Technologies Inc | US | unknown | $2.2M |
| Asgard Therapeutics | SE | series-a | $32.4M |
| ASSAYQUANT TECHNOLOGIES, INC. | US | unknown | $9.7M |
| Atavistik Bio | US | series-b+ | $120.0M |
| Atavistik Bio | US | series-b+ | $220.0M |
| ATLASXOMICS INC | US | unknown | $1.8M |
| Augustine Therapeutics | BE | series-a | $108.0M |
| Auragent Bioscience LLC | US | unknown | $2.0M |
| Auron Therapeutics, Inc. | US | unknown | $13.4M |
| AUTOIVF, INC. | US | unknown | $2.1M |
| Avenue Biosciences | FI | seed | $2.5M |
| Avenue Biosciences | FI | seed | $2.5M |
| Aviara Pharmaceuticals, Inc. | US | unknown | $2.0M |
| Aviceda Therapeutics | US | series-b+ | $300.0M |
| Avivomed Inc. | US | unknown | $5.0M |
| Azafaros | NL | series-b+ | $142.6M |
| BACSTITCH DNA INC. | US | unknown | $2.1M |
| baCta | FR | seed | $7.6M |
| BAEBIES, INC. | US | unknown | $2.0M |
| Basecamp Research | GB | series-b+ | $80.0M |
| BCN BIOSCIENCES LLC | US | unknown | $3.0M |
| Beeline Medicines | US | series-a | $300.0M |
| BIMINI Biotech | NL | seed | $3.5M |
| BIMINI Biotech | NL | seed | $3.5M |
| Bio Usawa Inc. | US | unknown | $1.7M |
| BioAesthetics Corporation | US | unknown | $2.0M |
| BioCopy | CH | series-a | $9.9M |
| BiocSol | BE | seed | $5.6M |
| Biofidelity | GB | series-a | $23.8M |
| Biomatter | LT | seed | $7.0M |
| Biorce | ES | seed | $6.5M |
| BIOSENSICS LLC | US | unknown | $2.0M |
| Biospyder Technologies, Inc. | US | unknown | $2.6M |
| Biotherapeutics, Inc. | US | unknown | $1.9M |
| BIOWEG | DE | series-a | $17.3M |
| BlossomHill Therapeutics | US | series-b+ | $84.0M |
| BlossomHill Therapeutics | US | series-b+ | $257.0M |
| BlueWhale Bio, Inc. | US | unknown | $5.0M |
| BMSEED LLC | US | unknown | $1.6M |
| Bonum Therapeutics, Inc. | US | unknown | $26.9M |
| BOSTON CELL STANDARDS INC. | US | unknown | $2.0M |
| Brenus Pharma | FR | series-a | $24.0M |